Effects of eicosapentaenoic acid on platelet activation markers and cell adhesion molecules in hyperlipidemic patients with Type 2 diabetes mellitus

Journal of Diabetes and its Complications

Volumn 17, Issue 3, 2003, Pages 153-159

  Nomura, Shosaku ^a   Kanazawa, Shigenori ^a   Fukuhara, Shirou ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Antioxidized LDL antibody; Eicosapentaenoic acid; Hyperlipidemia; Platelet derived microparticle; Type 2 diabetes mellitus

Indexed keywords

CD63 ANTIGEN; CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FIBRINOGEN RECEPTOR; GLYCOPROTEIN IB; ICOSAPENTAENOIC ACID; LIPOCORTIN 5; LOW DENSITY LIPOPROTEIN; MONOCLONAL ANTIBODY; PADGEM PROTEIN;

ADULT; AGED; ARTICLE; BLOOD VESSEL INJURY; CELL ADHESION; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERLIPIDEMIA; MALE; MONOCYTE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; THROMBOCYTE ACTIVATION;

EID: 0038300238     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8727(02)00172-1     Document Type: Article

References (43)

1. Baumgartner-Parzer S.M., Wagner L., Pettermann M., Gessl A., Waldhausl W. Modulation by high glucose of adhesion molecule expression in cultured endothelial cells. Diabetologia. 38:1995;1367-1370.
2. Beekhuizen H., van Furth R. Monocyte adherence to human vascular endothelium. Journal of Leukocyte Biology. 54:1993;363-378.
3. Bellomo G., Maggi E., Poli M., Agosta F.G., Bollati P., Finardi G. Auto-antibodies against oxidatively modified low density lipoproteins in NIDDM. Diabetes. 44:1995;60-66.
4. Berliner J.A., Territo M.C., Sevanian A., Ramin S., Kim J.A., Bamshad B., Esterson M., Fogelman A.M. Minimally modified low density lipoproteins stimulate monocyte endothelial interactions. Journal of Clinical Investigation. 85:1990;1260-1266.
5. Chobanian A.V. Single risk factor intervention may be inadequate to inhibit atherosclerosis progression when hypertension and hypercholesterolemia co-exist. Hypertension. 18:1991;130-131.
6. Cominacini L., Pasini A.F., Garbin U., Davoli A., De Santis A., Campagnola M., Rigoni A., Zenti M.G., Moghetti P., Lo Cascio V. Elevated levels of soluble E-selectin in patients with IDDM and NIDDM: relation to metabolic control. Diabetologia. 38:1995;1122-1124.
7. Croft K.D., Beilin L.J., Vandongen R., Rouse I., Masarei J. Leukocyte and platelet function and eicosanoid production in subjects with hypercholesterolaemia. Atherosclerosis. 83:1990;101-109.
8. Cushing S.D., Berliner J.A., Valente A.J., Territo M.C., Navab M., Parhami F., Gerrity R., Schwartz C.J., Fogelman A.M. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proceedings of the National Academy of Sciences of the United States of America. 87:1990;5134-5138.
9. Davies M.J., Gordon J.L., Gearing A.J.H., Pigott R., Wolf N., Katz D., Kyriakopoulos A. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM-1, and E-selectin in human atherosclerosis. Journal of Pathology. 171:1993;223-229.
10. Drake T.A., Hannani K., Fei H., Lavi S., Berliner J.A. Minimally oxidized LDL induces tissue factor expression in cultured human endothelial cells. American Journal of Pathology. 138:1991;601-607.
11. Dyerberg J., Bang H.O., Stoffersen E., Moncada S., Vane J.R. Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet. 2:1978;117-119.
12. Fogelman A., Schechter I., Seager J., Hokom M., Child J., Edwards P. Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in macrophages. Proceedings of the National Academy of Sciences of the United States of America. 77:1980;2214-2218.
13. Fries J.W.U., Williams A.J., Atkins R.C., Newman W., Lipscomb M.F., Collins T. Expression of VCAM-1 and E-selectin in an in vivo model of endothelial activation. American Journal of Pathology. 143:1993;725-737.
14. Guideline for diagnosis and treatment of hyperlipidemias in adults. Doumyakukouka. 25:1997;1-34.
15. Jonasson L., Holm J., Bondjers G., Hansson G.K. Regional accumulation of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis. 6:1986;131-138.
16. Kobayashi S., Hirai A., Terano T., Hamazaki T., Tamura Y., Kumagai A. Reduction in blood viscosity by eicosapentaenoic acid. Lancet. 2:1981;197.
17. Le Quan Sarc K.H., Mazeaud M., Astarie C., Duranthon V., Driss F., Devynck M.-A. Plasma lipids and platelet membrane fluidity in essential hypertension. Thrombosis and Haemostasis. 69:1993;70-76.
18. Libby P. Atheroma: more than mush. Lancet. 348:1996;S4-S7.
19. Mesri M., Altieri D.C. Endothelial cell activation by leukocyte microparticles. Journal of Immunology. 161:1998;4382-4387.
20. Miyake T., Nomura S., Komiyama Y., Miyazaki Y., Kagawa H., Masuda M., Takahashi H., Fujimura Y., Ikeda Y., Fukuhara S. Effect of a new monoclonal anti-glycoprotein IX antibody, KMP-9, on high shear-induced platelet aggregation. Thrombosis and Haemostasis. 78:1997;902-909.
21. Miyazaki Y., Nomura S., Miyake T., Kagawa H., Kitada C., Taniguchi H., Komiyama Y., Fujimura Y., Ikeda Y., Fukuhara S. High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles. Blood. 88:1996;3456-3464.
22. Murakami T., Komiyama Y., Masuda M., Kido H., Nomura S., Fukuhara S., Karakawa M., Iwasaka T., Takahashi H. Flow cytometric analysis of platelet activation markers CD62P and CD63 in patients with coronary artery disease. European Journal of Clinical Investigation. 26:1996;996-1003.
23. Neumann F.-J., Marx N., Gawaz M., Brand K., Ott I., Rokitta C., Sticherling C., Meinl C., May A., Schomig A. Induction of cytokine expression in leukocytes by binding of thrombin stimulated platelets. Circulation. 95:1997;2387-2394.
24. Nomura S., Komiyama Y., Miyake T., Miyazaki Y., Kido H., Suzuki M., Kagawa H., Yanabu M., Takahashi H., Fukuhara S. Amyloid β-protein precursor rich platelet microparticles in thrombotic disease. Thrombosis and Haemostasis. 72:1994;519-522.
25. Nomura S., Nagata H., Oda K., Kokawa T., Yasunaga K. Effects of EDTA on membrane glycoprotein IIb-IIIa complex: analysis using flow cytometry. Thrombosis Research. 47:1987;47-58.
26. Nomura S., Nakamura T., Cone J., Tandon N.N., Kambayashi J. Cytometric analysis of high shear induced platelet microparticles and effect of cytokines on microparticle generation. Cytometry. 40:2000;173-181.
27. Nomura S., Suzuki M., Katsura K., Xie G.L., Miyazaki Y., Miyake T., Kido H., Kagawa H., Fukuhara S. Platelet-derived microparticles may influence the development of atherosclerosis in diabetes mellitus. Atherosclerosis. 116:1995;235-240.
28. Osnes L.T.N., Westvik A.B., Kieruf P. Procoagulant and profibrinolytic activities of cryopreserved human monocytes. Thrombosis Research. 76:1994;373-383.
29. Packham M.A., Mustard J.F. The role of platelets in the development and complications of atherosclerosis. Seminars in Hematology. 23:1986;8-19.
30. Rajavahira T.B., Andalibi A., Territo M.C., Berliner J.A., Navab M., Fogelman A.M., Lusis A.J. Induction of endothelial cell expression of granulocyte and macrophage colony stimulating factors by modified low density lipoproteins. Nature. 344:1990;254-257.
31. Robinson R.A., Worfolk L., Tracy P.B. Endotoxin enhances the expression of monocyte prothrombinase activity. Blood. 79:1992;406-416.
32. Ross R. The pathogenesis of atherosclerosis: a prospective study for the 1990s. Nature. 362:1993;801-809.
33. Sims P.J., Faioni E.M., Wiedmer T., Shattil S.J. Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. Journal of Biological Chemistry. 263:1988;18205-18212.
34. Singer P., Jaeger W., Wirth M., Voigt S., Naumann E., Zimontkowski S., Hajdu I., Goedicke W. Lipid and blood pressure-lowering effect of mackerel diet in man. Atherosclerosis. 49:1983;99-108.
35. Sparow C.D., Parthasarathy S., Steinberg D. A macrophage receptor that recognizes oxidized LDL but not acetylated LDL. Journal of Biological Chemistry. 264:1989;2599-2604.
36. Springer T.A. Adhesion receptors of the immune system. Nature. 346:1990;425-434.
37. Terano T., Hirai A., Hamazaki T., Kobayashi S., Fujita T., Tamura Y., Kumagai A. Effect of oral administration of highly purified eicosapentaenoic acid on platelet function, blood viscosity and red cell deformity in healthy human subjects. Atherosclerosis. 46:1983;321-331.
38. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 20:1997;1183-1197.
39. Tschope D., Spangenberg P., Esser J., Schwippert B., Kehrel B., Rosen P., Gries F.A. Flow cytometric detection of surface membrane alterations and concomitant changes in the cytoskeletal actins status of activated platelets. Cytometry. 11:1990;652-656.
40. Venturini C.M., Kaplan J.E. Thrombin induces platelet adhesion to endothelial cells. Seminars in Thrombosis and Hemostasis. 18:1992;275-283.
41. Weyrich A.S., Elstad M.R., McEver R.P., McIntyre T.M., Moore K.L., Morrissey J.H., Prescott S.M., Zimmerman G.A. Activated platelets signal chemokine synthesis by human monocytes. Journal of Clinical Investigation. 97:1996;1525-1534.
42. Xie G.L., Nomura S., Fukuhara S. Annexin V expression and membrane vesiculation during activation of leukemic cell lines. Haemostasis. 27:1987;259-268.
43. syk activation by an anti-glycoprotein Ib monoclonal antibody. Blood. 89:1997;1590-1598.